Astal Labs Allots 1,13,300 Equity Shares on Warrant Conversion

Astal Laboratories Ltd's board approved the allotment of 1,13,300 equity shares with a face value of ₹10 each at an issue price of ₹40 each (including a premium of ₹30 per share). These shares were issued upon exercising the option available with warrant holders (non-promoter category) who converted warrants allotted on November 27, 2024, on a preferential basis. The paid-up equity capital increased from ₹436,856,320.00 to ₹437,989,320.00.